| HGNC Family | Non-coding RNAs |
| Name | HOXA cluster antisense RNA 3 |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Long non‐coding RNA HOXA‐AS3 functions as an important oncogenic and regulatory transcript in multiple human diseases by modulating diverse cellular processes including proliferation, migration, invasion, apoptosis, and chemoresistance. In glioblastoma, HOXA‐AS3 is markedly upregulated and promotes cell growth and epithelial–mesenchymal transition by acting as a competing endogenous RNA that sponges miR‐455–5p, thereby upregulating its downstream target USP3."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In lung adenocarcinoma, HOXA‐AS3 stabilizes HOXA6 mRNA through formation of an RNA duplex and its subcellular distribution is controlled via binding to NF110; its expression is further enhanced by histone acetylation, supporting tumor cell progression."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " In pulmonary arterial hypertension, HOXA‐AS3 promotes vascular smooth muscle cell proliferation and migration by sponging miR‐675–3p, which increases PDE5A expression and contributes to aberrant cell survival under hypoxic conditions."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Furthermore, conserved from early vertebrate evolution, HOXA‐AS3 participates in the coordinated regulation of overlapping HOX gene expression during development and cell differentiation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " In addition, HOXA‐AS3 exerts oncogenic roles in colorectal, pancreatic, bladder, and oral squamous cell carcinomas, where it functions as a molecular sponge for distinct microRNAs (for example, miR‐4319 in colorectal cancer, miR‐29c in pancreatic cancer, and miR‐455–5p in bladder cancer) to modulate key targets such as SPNS2, CDK6, and Notch1, thereby activating downstream signaling pathways including AKT and promoting chemoresistance."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "8"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Overall, these findings indicate that HOXA‐AS3 contributes to tumorigenesis and disease progression by acting as a ceRNA that fine‐tunes gene expression and epigenetic states. Its dysregulation across multiple cancers and vascular disorders correlates with aggressive clinical behavior and poor prognosis, rendering HOXA‐AS3 a promising candidate both as a prognostic biomarker and as a therapeutic target.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Wanghao Chen, Qiaoyu Li, Guilong Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA HOXA-AS3 promotes the malignancy of glioblastoma through regulating miR-455-5p/USP3 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.15788"}], "href": "https://doi.org/10.1111/jcmm.15788"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32918360"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32918360"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Hongyue Zhang, Ying Liu, Lixin Yan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased levels of the long noncoding RNA, HOXA-AS3, promote proliferation of A549 cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-018-0725-4"}], "href": "https://doi.org/10.1038/s41419-018-0725-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29899328"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29899328"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Zhong-Kui Li, Lu-Fang Gao, Xi-An Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA HOXA-AS3 Promotes the Progression of Pulmonary Arterial Hypertension through Mediation of miR-675-3p/PDE5A Axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Genet (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10528-021-10053-y"}], "href": "https://doi.org/10.1007/s10528-021-10053-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33687636"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33687636"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Neta Degani, Yoav Lubelsky, Rotem Ben-Tov Perry, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Highly conserved and cis-acting lncRNAs produced from paralogous regions in the center of HOXA and HOXB clusters in the endoderm lineage."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Genet (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pgen.1009681"}], "href": "https://doi.org/10.1371/journal.pgen.1009681"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34280202"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34280202"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Yang Jiang, Xiao-Yu Yu, Hui-Xin Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA HOXA-AS3 facilitates the malignancy in colorectal cancer by miR-4319/SPNS2 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Physiol Biochem (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13105-021-00832-x"}], "href": "https://doi.org/10.1007/s13105-021-00832-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34671931"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34671931"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Xiaoli Zhang, Hongbo Zhu, Xiaoguang Qu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Suppressing LncRNA HOXA-AS3 by CRISPR-dCas9 inhibits pancreatic cancer development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cancer (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/jca.62631"}], "href": "https://doi.org/10.7150/jca.62631"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34659534"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34659534"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Dajin Chen, Shangzhi Xie, Ying Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reduction of Bladder Cancer Chemosensitivity Induced by the Effect of HOXA-AS3 as a ceRNA for miR-455-5p That Upregulates Notch1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Oncol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fonc.2020.572672"}], "href": "https://doi.org/10.3389/fonc.2020.572672"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33643896"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33643896"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Yue Zhao, Rui Yao "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA HOXA-AS3 promotes cell proliferation of oral squamous cell carcinoma through sponging microRNA miR-218-5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2021.1978196"}], "href": "https://doi.org/10.1080/21655979.2021.1978196"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34698001"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34698001"}]}]}]}
|
| Synonyms | HOXA6AS |
| NCBI Gene ID | 100133311 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
HOXA-AS3 has 749 functional associations with biological entities spanning 3 categories (disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 14 datasets.
Click the + buttons to view associations for HOXA-AS3 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of HOXA-AS3 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of HOXA-AS3 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with HOXA-AS3 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of HOXA-AS3 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of HOXA-AS3 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of HOXA-AS3 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of HOXA-AS3 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of HOXA-AS3 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with HOXA-AS3 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with HOXA-AS3 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of HOXA-AS3 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of HOXA-AS3 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of HOXA-AS3 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of HOXA-AS3 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |